InvestorsHub Logo
Followers 0
Posts 73
Boards Moderated 0
Alias Born 03/17/2014

Re: ccfume post# 2165

Tuesday, 07/01/2014 3:48:31 AM

Tuesday, July 01, 2014 3:48:31 AM

Post# of 6143
I don't know where it will be in 6 months.

Partnering with Taxus was the best thing to happen to this company. I'd like to see the details of that partnership. Taxus will be selling their Taxol(paclitaxel)cancer drug ingredient here in the USA. There is always a shortage of paclitaxel.

http://www.ashp.org/menu/DrugShortages/CurrentShortages/bulletin.aspx?id=790

I've worked in the healthcare since 1992 and worked a lot in the Cardiac Thoracic ICU. If Gernerx gets approved they'll be a huge demand for it worldwide. I'm amazed a mid Phase III stock with a potential blockbuster drug is sitting under a $1.00

Yes I know the company has had it's share of set backs but what microcap biotech hasn't. I was just lucky to find this stock AFTER it did the reverse split and then falls back under a $1.00

I can see why many investors are sour on this company. But that's all part of investing in these microcap biotechs though. It's a rollercoaster ride to say the least. But if one finally hits as this one seems to be on the verge of it's a glorious day.

I emailed Jason Napodano about this company and he said he'd never heard of them but would look into them.

http://seekingalpha.com/author/jason-napodano-cfa

With the low float this thing has now the stock will rise extremely fast if Generx gets approval and they have a partner lined up to sell it. Someone like say Merck, Abbotts ,etc.